Peterson BA, Frizzera G, 1993, Semin Oncol, 20, 636
Yoshizaki K, Matsuda T, Nishimoto N, 1989, Blood, 74, 1360, 10.1182/blood.V74.4.1360.1360
Nishimoto N, 2005, Clin Rev Allergy Immunol, 28, 221, 10.1385/CRIAI:28:3:221
Nishimoto N, Sasai M, Shima Y, et a, 2000, Blood, 95, 56, 10.1182/blood.V95.1.56
10.1182/blood-2004-12-4602
10.1056/NEJM199403033300904
Corbellino M, Bestetti G, Scalamogn, 2001, Blood, 98, 3473, 10.1182/blood.V98.12.3473
Ocio EM, Sanchez-Guijo FM, Diez-Cam, 2005, Am J Hematol, 78, 302, 10.1002/ajh.20283
Pavlidis NA, Skopouli FN, Bai MC, B, 1990, Med Pediatric Oncol, 18, 333, 10.1002/mpo.2950180416
Dispenzieri A, Gertz MA, 2005, Curr Treat Options Oncol, 6, 255, 10.1007/s11864-005-0008-z
Casper C, 2005, B J Haematol, 129, 3, 10.1111/j.1365-2141.2004.05311.x
12. Actemra Intravenous Infusion 200 Safety Information Tabulation Results From Approval to June 30 2006 (published Oct. 2006).
Nishimoto N, 2006, Rheumatology, 35, 409
14. Actemra Intravenous Infusion 200 Information concerning the appropriate use (second edition: published Jul. 2005).
